UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Immutrin bags $87m for heart amyloid therapy

Source
Longevity Technology

Fresh funding backs a high-stakes attempt to do what current amyloidosis drugs still cannot: clear the buildup already damaging the heart.

UK-based biotech Immutrin has raised $87 million (£65 million) in an oversubscribed Series A round to push forward a next-generation antibody therapy aimed at a stubborn gap in amyloidosis treatment: removing the harmful protein buildup already lodged in patients’ tissues.